Literature DB >> 12766187

Membrane targeting of protein tyrosine phosphatase PTPL1 through its FERM domain via binding to phosphatidylinositol 4,5-biphosphate.

Guillaume Bompard1, Marianne Martin, Christian Roy, Françoise Vignon, Gilles Freiss.   

Abstract

PTPL1 is the largest known cytoplasmic protein tyrosine phosphatase (PTP) containing a FERM (four point-1, ezrin, radixin and moesin) domain. Enzyme localization and PTP-substrate specificity are thought to play crucial roles in the regulation of PTP activity, which determines their functions. Here we report that PTPL1 is predominantly localized at the apical face of plasma membrane enriched in dorsal microvilli when expressed in HeLa cells. By comparing localization of the full-length enzyme with its FERM domain or FERM-deleted PTPL1 construct, we first concluded that PTPL1-FERM domain is necessary and sufficient to address the wild-type enzyme at the membrane. Two potential phosphatidylinositol 4,5-biphosphate [PtdIns(4,5)P2]-binding motifs were identified within the PTPL1-FERM sequence. We further showed that mutation of both sites altered PTPL1 localization similarly to FERM domain deletion, and impaired its subcellular distribution as confirmed biochemically by cell-fractionation experiments. Using protein-lipid overlays, we demonstrated an interaction of the FERM domain of PTPL1 with PtdIns(4,5)P2, which was lost after mutation of potential PtdIns(4,5)P2-binding motifs. Moreover, neomycin, which masks PtdIns(4,5)P2 polar heads, was shown to decrease by 50% the association of PTPL1 with the cytoskeletal fraction. These results identify the crucial role of the FERM domain in PTPL1 intracellular targeting and demonstrate that localization of PTPL1 is regulated by phosphoinositide metabolism.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12766187     DOI: 10.1242/jcs.00448

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.285


  20 in total

1.  PTPL1/PTPN13 regulates breast cancer cell aggressiveness through direct inactivation of Src kinase.

Authors:  Murielle Glondu-Lassis; Mathilde Dromard; Magali Lacroix-Triki; Philippe Nirdé; Carole Puech; Dora Knani; Dany Chalbos; Gilles Freiss
Journal:  Cancer Res       Date:  2010-05-25       Impact factor: 12.701

Review 2.  Polyphosphoinositide-Binding Domains: Insights from Peripheral Membrane and Lipid-Transfer Proteins.

Authors:  Joshua G Pemberton; Tamas Balla
Journal:  Adv Exp Med Biol       Date:  2019       Impact factor: 2.622

Review 3.  PTPN13/PTPL1: an important regulator of tumor aggressiveness.

Authors:  Gilles Freiss; Dany Chalbos
Journal:  Anticancer Agents Med Chem       Date:  2011-01       Impact factor: 2.505

4.  Evidence for two CRIB domains in phospholipase D2 (PLD2) that the enzyme uses to specifically bind to the small GTPase Rac2.

Authors:  Hong-Juan Peng; Karen M Henkels; Madhu Mahankali; Mary C Dinauer; Julian Gomez-Cambronero
Journal:  J Biol Chem       Date:  2011-03-04       Impact factor: 5.157

Review 5.  Functions of intrinsic disorder in transmembrane proteins.

Authors:  Magnus Kjaergaard; Birthe B Kragelund
Journal:  Cell Mol Life Sci       Date:  2017-06-10       Impact factor: 9.261

6.  FERM domain phosphoinositide binding targets merlin to the membrane and is essential for its growth-suppressive function.

Authors:  Timmy Mani; Robert F Hennigan; Lauren A Foster; Deborah G Conrady; Andrew B Herr; Wallace Ip
Journal:  Mol Cell Biol       Date:  2011-03-14       Impact factor: 4.272

7.  Interaction of the protein tyrosine phosphatase PTPL1 with the PtdIns(3,4)P2-binding adaptor protein TAPP1.

Authors:  Wendy A Kimber; Maria Deak; Alan R Prescott; Dario R Alessi
Journal:  Biochem J       Date:  2003-12-01       Impact factor: 3.857

8.  The PDZ and band 4.1 containing protein Frmpd1 regulates the subcellular location of activator of G-protein signaling 3 and its interaction with G-proteins.

Authors:  Ningfei An; Joe B Blumer; Michael L Bernard; Stephen M Lanier
Journal:  J Biol Chem       Date:  2008-06-19       Impact factor: 5.157

9.  Ligation of erythrocyte CR1 induces its clustering in complex with scaffolding protein FAP-1.

Authors:  Ionita Ghiran; Aleksandra M Glodek; Gregory Weaver; Lloyd B Klickstein; Anne Nicholson-Weller
Journal:  Blood       Date:  2008-08-06       Impact factor: 22.113

10.  Structural basis for the autoinhibition of talin in regulating integrin activation.

Authors:  Esen Goksoy; Yan-Qing Ma; Xiaoxia Wang; Xiangming Kong; Dhanuja Perera; Edward F Plow; Jun Qin
Journal:  Mol Cell       Date:  2008-07-11       Impact factor: 17.970

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.